found that miR-16 was enriched in MSC-exosomes and could inhibit angiogenesis in vitro and in vivo by significantly downregulating vascular endothelial growth factor (VEGF) in breast cancer cells, and Pakravan K et al. This evidence concerns the gene VEGFA and breast carcinoma.